Trump has promised to ‘knock out’ pharmacy benefit managers. How the drug middlemen became a $557 billion industry that its customers love to hate
The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.
‘Knock out the middlemen’: A campaign promise Donald Trump should keep
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
Pharma is hopeful about Trump's second term — here's what to expect for drugmakers
Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...
Drugmakers Show Restraint on Price Increases in New Trump Era
The companies raised prices a median 4%, though some drugs will cost thousands of dollars more.
Modern Healthcare12d
Congress likely to stall RFK Jr.'s agenda, investors believe
But for all the noise, many Wall Street professionals believe the policy risk in the healthcare sector is lower than feared. ...
UnitedHealth, employer of slain exec Brian Thompson, found to have overcharged some cancer patients for drugs by over 1,000%
These include, but are not limited to, the big three drug middlemen known as pharmacy benefit managers (PBMs). According to ...
City of Columbus sues drug companies over insulin prices
Columbus joins the states of Arkansas, California, Kansas, Kentucky, Minnesota and Mississippi and other cities and counties ...
Insurancenewsnet.com12d
Arkansas lawmakers seek to ban prescription drug middlemen from owning pharmacies in the state
A proposed Arkansas law would forbid pharmacy benefit managers (PBMs) from holding or acquiring interest in retail pharmacy ...
Magnolia Reporter11d
Arkansas Advocate: Arkansas lawmakers seek to ban prescription drug middlemen from owning pharmacies in the state
A proposed Arkansas law would forbid pharmacy benefit managers (PBMs) from holding or acquiring interest in retail pharmacy ...